Cohance Lifesciences
Sunil Uttarwar is an accomplished professional with extensive experience in the pharmaceutical industry, currently serving as Chief Operating Officer Tech Ops at Cohance Lifesciences since March 2022. Prior to this role, Sunil held significant positions such as Vice President Operations at SUN PHARMA, overseeing multiple units, and Director Manufacturing Operations at Emcure Pharmaceuticals Limited, where responsibilities included managing operations at two sites. Notable previous roles also include Site Head for three API Units at Cipla Ltd., General Manager Operations at Alembic Pharmaceuticals, and General Manager Works at Elder Pharmaceuticals. Sunil's educational background includes a Bachelor's degree in Chemical Engineering from Birla Institute of Technology and Science and an MBA in Finance from ICFAI.
Cohance Lifesciences
Cohance Lifesciences is a global, merchant API platform. With 8 manufacturing units (including 5 USFDA approved units) and 2 R&D dedicated units, we serve our marquee clients as partner of choice in a range of niche Intermediates, API, Pharmaceutical Formulation intermediates (PFI), Formulations & Speciality chemicals across both Innovator and Generic molecules. We also specialise in highly specialised CRAMS and Clinical research. As a global player, we have presence in 60 countries and have a growing product basket of 80+ molecules backed by robust R&D and Infrastructure.